Aeglea Biotherapeutics shares owned by Morgan Stanley
Quarter-by-quarter ownership of Aeglea Biotherapeutics (SYRE) shares owned by Morgan Stanley
from 13F filings
Historical chart of Morgan Stanley investment in Aeglea Biotherapeutics
Tip: Access up to 7 years of quarterly data
All positions including Aeglea Biotherapeutics held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Aeglea Biotherapeutics by Morgan Stanley
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-06-30 | $10M | 671k | 14.97 |
| 2024-12-31 | $5.9M | 255k | 23.28 |
| 2024-09-30 | $7.2M | 244k | 29.41 |
| 2024-06-30 | $9.6M | 409k | 23.51 |
| 2024-03-31 | $1.9M | 51k | 37.93 |
| 2023-12-31 | $861 | 40 | 21.53 |
| 2023-09-30 | $563 | 46 | 12.25 |